|Bid||264.70 x 1000|
|Ask||264.97 x 1000|
|Day's Range||263.08 - 267.99|
|52 Week Range||240.33 - 315.95|
|Beta (3Y Monthly)||0.40|
|PE Ratio (TTM)||552.52|
|Earnings Date||Oct 30, 2019 - Nov 4, 2019|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||354.49|
This All-New Family Production Will Make Its Debut At Hulu Theater at Madison Square Garden This Holiday Season THE LIMITED HOLIDAY ENGAGEMENT RUNS FROM DECEMBER 12 THROUGH.
Is The Madison Square Garden Company (NYSE:MSG) a good place to invest some of your money right now? We can gain invaluable insight to help us answer that question by studying the investment trends of top investors, who employ world-class Ivy League graduates, who are given immense resources and industry contacts to put their financial […]
The release of the new film corresponds with New York Comic Con, where thousands of comic book and movie fans typically convene in costume.
The Madison Square Garden Company (MSG) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
The New York Knicks and Hospital for Special Surgery (HSS), announced today a renewed and expanded multi-year marketing partnership designating HSS as the Official Hospital Partner of the New York Knicks, Westchester Knicks and Knicks Gaming. The agreement provides HSS with premier brand integration across the Knicks’ unrivaled set of assets, including digital platforms, in-game signage and the Junior Knicks youth basketball platform.
MSG Networks Inc. shares rose more than 9% in the extended session Thursday after the operator of regional sports and entertainment networks spun off from Madison Square Garden Co. said its board of directors has authorized a $300 million stock buyback program. That brings MSG Networks' available authorization to $436 million, the company said. The company also said it plans a modified Dutch auction to buy up to $250 million in shares at a per-share price between $15.00 and $17.50. "MSG Networks has a strong balance sheet and generates robust free cash flow, which we will use to execute a stock repurchase program that provides us with flexibility to take advantage of market opportunities. We understand the media landscape is evolving, but remain confident in the long-term prospects for our business and our continued ability to create value for shareholders," Chief Executive Andrea Greenberg said in a statement. The stock ended the regular trading day up 1.2%.
NEW YORK, Aug. 28, 2019 -- The Madison Square Garden Company (NYSE: MSG), MSG Networks Inc. (NYSE: MSGN) and AMC Networks Inc. (NASDAQ: AMCX) today announced that Vice.
Madison Square Garden's (MSG) top line in fourth-quarter fiscal 2019 was impacted by the Entertainment and Sports segments' dismal performance.
The bullish start to the week fizzled out on Tuesday, despite mostly-optimistic chatter. Credit Suisse's "recession dashboard" says there's not one in sight. "Key signals such as labor and credit trends remain quite healthy," explains Credit Suisse chief U.S. equity strategist Jonathan Golub.And, while he laments it, fund manager Kyle Bass made the case that central banks are going to continue doing anything and everything they can to keep the global economy propped up. JPMorgan's global head of quantitative and derivatives strategy Marko Kolanovic even went as far as saying last week's temporary inversion of the yield curve wasn't the cause for worry it might normally be.InvestorPlace - Stock Market News, Stock Advice & Trading TipsDisruption in Europe may have been the crux of the weakness. The United Kingdom may postpone the selection of the Bank of England's next governor until after Brexit, though Brexit itself remains up in the air. In Italy, Prime Minister Giuseppe Conte announced his resignation, simultaneously criticizing Deputy Prime Minister Matteo Salvini for calling for the no-confidence vote that led to his exit.Both cast a cloud of uncertainty over Europe, which was already struggling to maintain economic growth. * 10 Undervalued Stocks With Breakout Potential All told, the S&P 500 snapped a three-day win streak with its 0.53% setback on Tuesday. The Dow Jones Industrial Average wasn't quite as damaged, falling 0.37%, while the NASDAQ Composite ended the day 0.45% lower. Top News in the Stock Market TodayIt had little impact on shares, but it's a developing story that could matter more in the future. That is, on Tuesday, a string of personnel exits from the healthcare arm being developed by Apple (NASDAQ:AAPL) was thrust into the spotlight. The report named six key people who'd left the company in recent months, reportedly frustrated about the direction Apple's health business was moving. Some employees interviewed anonymously suggested tensions had been mounting for some time. The disruption calls into question how much traction Apple's health initiatives will garner in the foreseeable future.Walt Disney Company (NYSE:DIS) joined General Electric (NYSE:GE) as a recent accusee of misleading accounting, though in this case, the red flag is being waved by a former insider. Sandra Kuba, formerly a senior financial analyst with Disney that was terminated in 2017, suggested the entertainment giant had habitually reported more revenue than it had actually generated. Kuba went as far as to formally inform the Securities and Exchange Commission.Walt Disney denied the accusation, and given the small gain DIS stock mustered on an otherwise bearish day, investors aren't concerned.Investors are concerned about Sarepta Therapeutics (NASDAQ:SRPT), however, after the Food and Drug Administration responded to its most recent drug approval request with less than open arms. The FDA sent a so-called Complete Response Letter to Sarepta regarding concerns and questions it had about its Duchenne muscular dystrophy drug that's been in development for years.The letter is not a rejection, but it does suggest the FDA is so far unconvinced that the drug is worth greenlighting. SRPT stock fell more than 15% on the news. Big MoversDespite its clear capacity to put and keep itself in the spotlight, "meatless" meat company Beyond Meat (NASDAQ:BYND) hasn't impressed the analyst community. Until Tuesday, no analyst was willing to call the stock a "Buy" … that is, until today. JPMorgan analyst Ken Goldman upgraded BYND stock to that rating, explaining "We are encouraged that velocity -- sales per distribution point -- has been the primary driver of recent acceleration, as it suggests the products are catching on with consumers."The call pushed Beyond Meat shares up by more than 6%.It's not much of a household name, but for households that own a piece of electronics manufacturer Cemtrex (NASDAQ:CETX), that stake is worth 36% more today. Shares jumped nearly 30% in regular-hours action on Tuesday following an impressive second quarter report that saw an additional 6% advance in after-hours action. The promise of real profits within the next few quarters fanned the bullish flames.Not every big mover was necessarily a winner though. Madison Square Garden (NYSE:MSG) tumbled nearly 9% after the company's second-quarter bottom line fell short of estimates. Its new project in Las Vegas is proving costly but not fruitful.As of the time of this writing, James Brumley did not hold a position in any of the aforementioned securities. To learn more about James, visit his site at jamesbrumley.com, or follow him on twitter at @jbrumley. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 10 Cheap Dividend Stocks to Load Up On * The 10 Biggest Losers from Q2 Earnings * 5 Dependable Dividend Stocks to Buy The post Stock Market Today: Beyond Meat Makes a Friend on Wall Street appeared first on InvestorPlace.
The Madison Square Garden Co (NYSE: MSG ) shares are trading lower after the company reported worse-than-expected fourth-quarter EPS and sales results . The company reported losses of $3.08 per share, ...
Investing.com - Madison Square Garden (NYSE:MSG) slumped on Tuesday after its fiscal fourth-quarter earnings failed to meet forecasts due to weakness in its sports business.
The Madison Square Garden Company (MSG) delivered earnings and revenue surprises of -31.62% and -4.42%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
Madison Square Garden Co. reported Tuesday a wider fiscal fourth-quarter loss and revenue that fell more than expected, amid weakness in its MSG Sports business. The stock was still inactive in premarket trading. The net loss for the quarter to June 30 was $73.2 million, or $3.08 a share, after a loss of $46.1 million, or $1.94 a share, in the same period a year ago. The FactSet consensus for net EPS was $2.71. Revenue fell 17% to $263.6 million, below the FactSet consensus of $270.1 million. MSG Entertainment revenue slipped 6% to $174.0 million, above the FactSet consensus of $172.5 million, and MSG Sports revenue dropped 32% to $90.0 million to miss expectations of $102.1 million. MSG said the decrease in revenue was primarily due to the impact of ASC Topic 606, a new accounting standard for revenue from contracts with customers, partially offset by higher event-related revenue from other live sporting events. "Looking ahead, we remain confident in the strength of our core businesses and expect fiscal 2020 to be an important year as we work to complete the proposed sports spin-off and begin to usher in the company's next chapter, with MSG Sphere in Las Vegas starting to take shape," said Chief Executive James Dolan. The stock has gained 9.6% year to date, while the S&P 500 has rallied 16.6%.
NEW YORK, Aug. 20, 2019 -- The Madison Square Garden Company (NYSE: MSG) today reported financial results for the fourth quarter and fiscal year ended June 30, 2019. For.